458 chapter 11 Table 2. Clinical, histopathological and GWLOH data per included nodule (n=30) no. Sex Age Lesion size (mm) Histopathology FU status MD material Tumour cell % 1 F 74 15 NH-H 5 NED cytology ≥90% 2 F 39 35 NH-H 8 NED cytology ≥30% 3 F 54 40 NH-H 13 NED cytology ≥30% 4 F 76 27 OA 0 NED histology ≥50% 5 F 66 19 OA 7 NED cytology ≥90% 6 M 55 49 OA 5 NED histology ≥80% 7 F 48 17 OA 1 NED cytology ≥30% 8 F 62 40 OA 2 NED cytology ≥30% 9 F 49 58 OA ? ? histology ≥50% 10 F 76 25 OA ? ? histology ≥70% 11 F 55 14 OA 6 NED histology ≥50% 12* M 44 25 OA ? ? histology ≥70% 13* M 44 25 OA ? ? histology ≥70% 14 M 69 3 OA ? ? histology ≥70% 15 F 67 10 mi-OCA, pT1aN0M0 36 NED histology ≥50% 16 F 63 20 mi-OCA, pT1bN0M0 38 NED histology ≥80% 17 F 50 22 mi-OCA, pT2N0M0 ? ? histology ≥80% 18 F 33 27 mi-OCA, pT2N0M0 22 NED histology ≥60% 19 M 78 36 mi-OCA, pT2N0M0 ? ? histology ≥80% 20 V 49 6 mi-OCA, pT1aN0M0 4 NED cytology ≥30% 21 M 46 14 mi-OCA, pT1bN0M0 6 NED histology ≥80% 22 F 39 50 mi-OCA, pT3N0M0 17 NED cytology ≥50% 23 M 57 27 mi-OCA, pT2N1bM1, with pulmonary and renal metastases 161 AWD histology ≥70% 24 F 51 44 mi-OCA, pT3N0M0 7 AWD cytology ≥50% 25 M 54 50 mi-OCA, pT3N0M0 11 AWD histology ≥60% 26 F 54 78 mi-OCA, pT3N0M0 1 AWD histology ≥80% 27 M 73 48 mi-OCA, pT3N0M0 ? ? core biopsy ≥70% 28 M 46 80 wi-OCA, pT3N0M1, with extensive vascular invasion, pulmonary and osseous metastases 20 AWD cytology ≥30% 29 M 61 85 wi-OCA, pT3N1bM1, with extensive lnn, pulmonary and osseous metastases 17 AWD cytology ≥80% 30 M 49 40 wi-OCA, pT3N1bM1, with extensive lnn, pulmonary, and osseous metastases 20 DOD histology ≥50%
RkJQdWJsaXNoZXIy MTk4NDMw